Association between exposure to combustion-related air pollution and multiple sclerosis risk DOI Creative Commons
Anna Karin Hedström, David Segersson, Jan Hillert

et al.

International Journal of Epidemiology, Journal Year: 2023, Volume and Issue: 52(3), P. 703 - 714

Published: Jan. 11, 2023

Abstract Background Smoking and occupational pulmonary irritants contribute to multiple sclerosis (MS) development. We aimed study the association between ambient air pollution MS risk potential interaction with human leukocyte antigen (HLA)-DRB1*15:01 allele. Methods Exposure combustion-related was estimated as outdoor levels of nitrogen oxides (NOx) at participants’ residence locations, by spatially resolved dispersion modelling for years 1990–18. Using two population-based case-control studies (6635 cases, 8880 controls), NOx were associated calculating odds ratios (OR) 95% confidence intervals (CI) using logistic regression models. Interaction high HLA-DRB1*15:01 allele regarding calculated attributable proportion due (AP). In addition, a register performed comprising all cases in Sweden who had received their diagnosis 1993 2018 (n = 22 173), 10 controls per case randomly selected from National Population register. Results Residential risk. (3-year average) exceeding 90th percentile (24.6 µg/m3) an OR 1.37 (95% CI 1.10–1.76) compared below 25th (5.9 µg/m3), trend increasing (P <0.0001). A synergistic effect observed (exceeding lower quartile among controls) (AP 0.26, 0.13–0.29). Conclusions Our findings indicate that moderate may play role

Language: Английский

Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells DOI Creative Commons
Daiya Ohara, Yusuke Takeuchi, Keiji Hirota

et al.

Cellular and Molecular Immunology, Journal Year: 2024, Volume and Issue: 21(11), P. 1183 - 1200

Published: Oct. 8, 2024

The IL-23 signaling pathway in both innate and adaptive immune cells is vital for orchestrating type 17 immunity, which marked by the secretion of signature cytokines such as IL-17, IL-22, GM-CSF. These proinflammatory mediators play indispensable roles maintaining intestinal equilibrium mucosal host defense; however, their involvement has also been implicated pathogenesis chronic inflammatory disorders, bowel diseases autoimmunity. However, implications immunity across diverse inflammation models are complex. This review provides a comprehensive overview multifaceted these gut homeostasis perturbing barrier integrity, leading to acute various infection colitis. Additionally, this focuses on interconnecting multiple organs autoimmune conditions, with particular emphasis arthritis neuroinflammation driven T primed within microenvironment.

Language: Английский

Citations

6

Improvements in Gut Microbiome Composition and Clinical Symptoms Following Familial Fecal Microbiota Transplantation in a Nineteen-Year-Old Adolescent With Severe Autism DOI Open Access

Sabine Hazan,

Jonathan Haroon,

Sheldon Jordan

et al.

Journal of Medical Cases, Journal Year: 2024, Volume and Issue: 15(4-5), P. 82 - 91

Published: May 1, 2024

This case report describes a novel therapy for patients with severe autism spectrum disorder (ASD) that is worth further investigation. A 19-year-old male adolescent ASD, who was not responding to standard treatment received fecal microbiota transplant (FMT) using donor material from his typically developing female sibling. The patient's ASD symptoms were assessed by assessors blind the past symptomatology. Assessors used Childhood Autism Rating Scale (CARS), an observation-based rating scale assess developmental delay in children (range of CARS scores 15 - 60; score > 28 indicative autism; higher positively correlated degree severity), at baseline and again six timepoints post-FMT. patient experienced marked improvements microbiome diversity composition over year half period followed FMT procedure. Additionally, previously nonverbal said first two words reduction aggression 1-month To authors' knowledge, this demonstrate use familial ASD. Given symptom post-FMT tend occur younger patients, authors hypothesize may be important factor contributed improved outcomes older child.

Language: Английский

Citations

5

Anti-CD20 monoclonal antibody (mAb) therapy and colitis: A case series and review DOI

Sarah Tolaymat,

Kanika Sharma, Yusuf Kagzi

et al.

Multiple Sclerosis and Related Disorders, Journal Year: 2023, Volume and Issue: 75, P. 104763 - 104763

Published: May 15, 2023

Language: Английский

Citations

13

Applied physiology: gut microbiota and antimicrobial therapy DOI
Andrey V. Suslov, Alin Panas, Mikhail Y. Sinelnikov

et al.

European Journal of Applied Physiology, Journal Year: 2024, Volume and Issue: 124(6), P. 1631 - 1643

Published: April 29, 2024

Language: Английский

Citations

5

Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis DOI Open Access
Maddalena Sparaco, Simona Bonavita

Journal of Clinical Medicine, Journal Year: 2022, Volume and Issue: 11(7), P. 1941 - 1941

Published: March 31, 2022

Urinary, bowel, and sexual dysfunctions are the most frequent disabling pelvic floor (PF) disorders in patients with multiple sclerosis (MS). PF dysfunction negatively impacts performance of daily living activities, walking, physical dimension quality life (QoL) people MS. Patient-reported outcomes on sphincteric functioning could be useful to detect their impact patients’ lives. rehabilitation proposed by Kegel is based a series regularly repeated exercises for “the functional restoration perineal muscles”. Over time, various therapeutic modalities have been added muscles exercises, through application or instrumental techniques, such as intravaginal neuromuscular electrical stimulation, electromyographic biofeedback, transcutaneous tibial nerve stimulation. has applied MS treatment, improvements lower urinary tract symptoms severity, QoL, level anxiety depression, dysfunction. This review aims examine different evaluate highlight its advantages limits, suggesting multidisciplinary management disorders, well-deserved space reserved rehabilitation.

Language: Английский

Citations

18

COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels DOI Creative Commons
William Danilo Fernandes de Souza, Denise Morais da Fonseca,

Alexandrina Sartori

et al.

Cells, Journal Year: 2023, Volume and Issue: 12(5), P. 684 - 684

Published: Feb. 21, 2023

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an exceptionally transmissible and pathogenic that appeared at the end of 2019 triggered a pandemic disease, known as disease (COVID-19). COVID-19 can evolve into severe associated with immediate delayed sequelae in different organs, including central nervous system (CNS). A topic deserves attention this context complex relationship between SARS-CoV-2 infection multiple sclerosis (MS). Here, we initially described clinical immunopathogenic characteristics these two illnesses, accentuating fact can, defined patients, reach CNS, target tissue MS autoimmune process. The well-known contribution viral agents such Epstein-Barr virus postulated participation risk factor for triggering or worsening are then described. We emphasize vitamin D scenario, considering its relevance susceptibility, severity control both pathologies. Finally, discuss experimental animal models could be explored to better understand interplay diseases, possible use adjunct immunomodulator treat them.

Language: Английский

Citations

11

Milk and multiple sclerosis: A possible link? DOI

Caleb R. Morin,

Maria-Elizabeth Baeva, Morley D. Hollenberg

et al.

Multiple Sclerosis and Related Disorders, Journal Year: 2024, Volume and Issue: 83, P. 105477 - 105477

Published: Jan. 28, 2024

Language: Английский

Citations

4

C16 peptide and angiopoietin-1 alleviate the side effects of glucocorticoids in a rat multiple sclerosis model DOI
Han Qu, Xiaoxiao Fu, Shu Han

et al.

Life Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 123402 - 123402

Published: Jan. 1, 2025

Language: Английский

Citations

0

Role of microbiome gut-brain axis in brain disorders DOI
Smriti Parashar, Devesh U. Kapoor, Rupesh K. Gautam

et al.

Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 297 - 323

Published: Jan. 1, 2025

Language: Английский

Citations

0

Overview of microbiota gut-brain-axis DOI
Ruchika Sharma,

Kuttiappan Anitha,

Neeraj Mishra

et al.

Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 18

Published: Jan. 1, 2025

Language: Английский

Citations

0